BRIEF-Pfizer Enters Into Exclusive Licensing Agreement With 3SBio

Reuters
20 May
BRIEF-Pfizer Enters Into Exclusive Licensing Agreement With 3SBio

May 19 (Reuters) - Pfizer Inc PFE.N:

  • PFIZER ENTERS INTO EXCLUSIVE LICENSING AGREEMENT WITH 3SBIO

  • PFIZER INC - 3SBIO TO RECEIVE $1.25 BILLION UPFRONT PAYMENT

  • PFIZER INC - 3SBIO ELIGIBLE FOR MILESTONE PAYMENTS UP TO $4.8 BILLION

  • PFIZER INC - TO MAKE $100 MILLION EQUITY INVESTMENT IN 3SBIO

  • PFIZER INC - DEAL EXPECTED TO CLOSE IN THIRD QUARTER

Source text: ID:nBw79mTyha

Further company coverage: PFE.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10